Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-12 10:34 am Purchase | 13G | TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA | FMR LLC | 62,740,762 5.537% | 33,877,274 (+117.37%) | View |
2024-04-09 10:26 am Purchase | 13G | TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA | Phoenix Financial Ltd. | 54,144,997 4.830% | 54,144,997 (New Position) | View |
2024-02-01 08:03 am Purchase | 13G | TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA | Phoenix Financial Ltd. | 60,522,178 5.400% | 60,522,178 (New Position) | View |
2023-06-09 12:32 pm Sale | 13G | TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA | Capital Research Global Investors | 0 0.000% | -114,793,989 (Position Closed) | View |
2023-02-13 3:32 pm Sale | 13G | TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA | Capital Research Global Investors | 114,793,989 10.300% | -17,556,761 (-13.27%) | View |
2022-02-11 12:22 pm Purchase | 13G | TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA | Capital Research Global Investors | 132,350,750 12.000% | 2,210,503 (+1.70%) | View |
2021-02-16 3:58 pm Purchase | 13G | TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA | Capital Research Global Investors | 130,140,247 11.900% | 130,140,247 (New Position) | View |
2021-02-11 4:18 pm Purchase | 13G | American Well Corp AMWL | TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA | 10,666,664 5.300% | 10,666,664 (New Position) | View |
2021-02-03 1:13 pm Sale | 13G | TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA | WELLINGTON MANAGEMENT GROUP LLP | 310,793 0.030% | -80,813,203 (-99.62%) | View |
2020-02-14 12:03 pm Purchase | 13G | TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA | Capital Research Global Investors | 130,950,677 11.900% | 8,996,394 (+7.38%) | View |
2020-02-05 4:32 pm Sale | 13G | TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA | FRANKLIN RESOURCES INC BEN | 19,916,016 1.800% | -44,212,516 (-68.94%) | View |
2020-01-28 11:02 am Purchase | 13G | TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA | WELLINGTON MANAGEMENT GROUP LLP | 81,123,996 7.430% | 81,123,996 (New Position) | View |